Stifel Europe

📣 Stifel is pleased to have served as Sole Global Coordinator and Sole Bookrunner to ADOCIA (ADOC), a biotechnology company specialising in therapeutic solutions for metabolic diseases, on the successful completion of its EUR 10 million Follow-On Offering. 🧬 ADOCIA is a leading French biotechnology company focused on improving treatments diabetes and obesity. Leveraging a broad portfolio of proprietary peptide and drug-delivery technology platforms, the company aims to make existing therapies more effective, more convenient, and more accessible for patients. 💼 The offering proceeds will help ADOCIA developing its new long-acting peptide platform AdoXLongTM, with an initial application on a monthly injectable semaglutide formulation, and scaling up its industrial manufacturing processes for BioChaperone®. 🌍 This transaction reinforces our strength in life sciences capital markets and our commitment to supporting innovative biotechnology companies driving therapeutic progress across metabolic diseases and beyond.

🚀 Stifel is pleased to serve as Private Placement Agent to Cereno Scientific, an innovative biotech developing treatments for rare cardiovascular and pulmonary diseases, on a SEK 350 million Loan Financing to refinance its debt and fund its lead clinical program. 🧬 Cereno Scientific continues to build strong momentum, with encouraging trial results for its lead treatment targeting pulmonary arterial hypertension (PAH). The company has made meaningful progress over the past year, strengthening its position and moving closer to bringing new, much-needed therapies to patients. 💡 The Loan Financing, plus a concurrent SEK 100 million Directed Issue executed by the company, gives Cereno Scientific the support it needs for its next phase of development. The Loan Financing was provided by Fenja Capital, a long-time supporter of the company. 🤝 This transaction highlights Stifel Europe’s ability to deliver fast, effective debt financing solutions for leading European biotech companies, using targeted investor outreach and deep sector expertise to secure a strong outcome under a tight timeline.

🌍 Stifel is pleased to have acted as Sole Placement Agent to ATLANTIC GROUP S.A., a leading pan-African conglomerate, on securing USD 150 million of debt financing to support the acquisition of the Tongon Gold Mine in Côte d’Ivoire from Barrick Gold Investments. 💼 ATLANTIC GROUP S.A., one of West Africa’s most diversified and influential business groups, has built a 40-year track record of driving industrial development across the region. Its expansion into gold mining marks a strategic step in strengthening Africa’s resource value chains and enhancing local economic participation. ⛏️ This strategic financing was arranged under an accelerated timeline, with Appian Capital Advisory providing a USD 150 million financing package structured around a mix of streaming and debt facilities. 🤝 At Stifel Europe, we are proud to support industrial leaders in executing transformative transactions that advance economic development across all regions.

📣 Stifel is pleased to serve as Sole Financial Advisor to Kaelus, a wireless network technology provider and its shareholders on the company’s intended sale to Baylin Technologies Inc., global wireless tech group. 📡 Kaelus is a Stockholm-based leader in advanced telecom solutions, delivering next-generation antennas, RF conditioning tools, and industry-leading PIM test & measurement systems that enhance the performance and reliability of 5G and future networks. 🤝 This strategic combination brings together Kaelus’s high-performance RF and testing capabilities with Baylin’s diversified wireless technology portfolio, strengthening the group’s ability to meet accelerating global connectivity demands. 🌍 This transaction reinforces Stifel Europe’s expertise in advising innovative technology companies driving the future of wireless infrastructure. We are proud to support industry leaders enabling smarter, faster, and more reliable networks worldwide.

🤝 Stifel is pleased to have served as Exclusive Financial Advisor to The Compound Company, a leading Dutch producer of technical compounds and grafted polymers, on its intended sale to Industrie Polieco - M.P.B. S.p.A., an Italy-based multinational recognised as European leader in polyethylene and polypropylene solutions. 🏭 The Compound Company develops cutting-edge polymer innovations under its Yparex® and EcoForte® brands. From advanced adhesion technologies to high-performance thermoplastic compounds, its solutions power next-generation applications across packaging, automotive, construction, solar PV, and industrial markets. 🌍 Through a tailored global auction, Stifel’s Global Chemicals team identified the ideal strategic partner, attracting top-tier strategic and private equity participants. This outcome reinforces our strength in cross-border specialty chemicals transactions. 🚀 At Stifel Europe, we are proud to support innovative materials and chemicals leaders driving performance, sustainability, and advanced manufacturing across industries.

🌐 Stifel is pleased to have acted as Sole Financial Advisor to Centreon, a leading European provider of IT monitoring and observability solutions, on securing a strategic investment from Sixth Street.   💡 Centreon makes digital performance visible, measurable, and actionable, enabling over 250,000 users in 60 countries to ensure the reliability of their IT environments.   💻 This strategic partnership with Sixth Street, a global investment firm with over $115bn in AuM and deep software expertise, will accelerate Centreon’s growth and innovation roadmap while preserving its sovereignty and entrepreneurial spirit.   🌍 At Stifel Europe, we are proud to support software leaders driving digital performance across industries.

✨ Bringing together senior leaders from high-growth technology and healthcare companies across the DACH region for an evening of insights, meaningful conversations, and fresh perspectives all in the heart of Munich.    A few weeks ago, Greg Revenu, European Head of Advisory & Equities at Stifel, opened the 6th edition of our CXO Dinner setting the stage for a dynamic discussion on what’s shaping today’s most vibrant markets.    Key insights from the discussion included:    💧 Liquidity is now a strategic lever, those who proactively shape their liquidity timeline will lead the next cycle.  🔧 Flexible, blended financing structures are becoming the new standard as companies balance growth, alignment, and capital efficiency.  🌍 Europe is entering a new competitive phase where innovation depth and a modernizing capital ecosystem can unlock global-scale impact. 🙏 A big thank you to all participants for making this edition such a success. Stay tuned for our next CXO Dinner in July 2026! Interested in diving deeper into the topics discussed at our recent CXO Dinner? You can access the full event presentation by just checking the comments below. Greg Revenu, Clifford Siegel, Falk Mueller-Veerse, Fabian Zimmer, Serge Licht, Jutta Wuebken, Sebastian Schirl, Valeriy Izrailevych Tobias Brix, Volker Rofalski, Jan Kurschner, Burkhardt Frick, Arne Dehn, Florian Stillger, Isabelle Villey, PhD MBA, Patrick Prügger, Jürgen Laakmann, Andreas Weinert, Andreas Sichert, Volker Rofalski, Enno Spillner, Oliver Schlueter, Maximilian Wühr

🌐 Stifel is pleased to have acted as sole financial advisor to nextProtein, an AgTech company specialised in the production of insect-based protein, on securing its €18 million Series B funding round with major impact investors. 🪲 nextProtein’s proprietary technology produces high-quality insect-based protein and oil from black soldier fly larvae raised on low-grade agricultural by-products. These ingredients support aquaculture, livestock, and pet nutrition while significantly reducing land, water, and carbon use—driving the transition toward more sustainable agriculture and tackling global resource scarcity. 💼 Institutional investors include SWEN Capital Partners, a leading sustainable investment firm managing nearly €10 billion in assets, and British International Investment, the UK’s development finance institution and impact investor supporting businesses that address poverty and the climate crisis across 66 countries. This marks another landmark transaction for Stifel’s Climate and Industrial Tech practice in Europe. Other notable transactions this year include an €84.8m equity raise for Avantium, and the announced €245m investment of MARA Holdings in EdF’s subsidiary, Exaion. 🤝 At Stifel Europe, we are proud to support companies driving sustainable technological transformation across global markets.

📅 Ready for lift-off? Mark your calendars: this Wednesday November 26 !   The Euronext Tech Leaders Forum is a must-attend event for Europe’s tech innovators and growth leaders. This 4th edition brings together executives from both listed and private tech companies, international investors, and key ecosystem partners for workshops and networking with Euronext’s global brokers. 🎙 Join us at our workshop at 14:30: Europe's Space IPOs: Ready for lift-off? with Florent Roulet, Investment Banking Managing Director at Stifel Europe, Antoine Lebourgeois, CFA, Equity Research Senior Associate at Stifel IRIS and Julien Merceron, CFO at Exotrail. 🌌 Let’s connect! Whether you’re exploring private capital, preparing for an IPO, or looking for tailored growth solutions, we’re here to help accelerate your journey.

🌐 Stifel is pleased to have acted as Sole Financial Advisor to Logiprem-F, a leading provider of prescription software for neonatal and petriatric intensive care, on its acquisition by EVOLUCARE Technologies, French subsidiary of Gpi Group S.p.A. 🚼 Logiprem-F is revolutionising neonatal and pediatric intensive care units by reducing prescription errors and improving patient outcomes. As a leading SaaS player in France, their solution ensures safer, more reliable care in complex pediatric settings. This acquisition not only broadens Gpi Group's Critical Care portfolio, which includes cutting-edge software for intensive care, operating rooms, and anesthesia, but also paves the way for further growth into key European markets. 🌍 At Stifel Europe, we are proud to support healthcare technology innovators improving outcomes for patients worldwide.